Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-125,780
Closed -$10.1M 83
2019
Q1
$10.1M Hold
125,780
0.13% 37
2018
Q4
$11.6M Hold
125,780
0.17% 34
2018
Q3
$11.9M Sell
125,780
-17,491
-12% -$1.66M 0.15% 38
2018
Q2
$13.3M Hold
143,271
0.18% 33
2018
Q1
$13.6M Hold
143,271
0.21% 30
2017
Q4
$13.9M Hold
143,271
0.2% 32
2017
Q3
$12.7M Sell
143,271
-27,776
-16% -$2.11M 0.18% 38
2017
Q2
$12.4M Buy
171,047
+90,222
+112% +$6.07M 0.19% 40
2017
Q1
$5.27M Hold
80,825
0.09% 52
2016
Q4
$5.06M Sell
80,825
-26,675
-25% -$1.63M 0.1% 54
2016
Q3
$6.78M Hold
107,500
0.12% 42
2016
Q2
$6.66M Hold
107,500
0.13% 45
2016
Q1
$6.14M Hold
107,500
0.12% 45
2015
Q4
$6.37M Sell
107,500
-120,000
-53% -$6.91M 0.11% 50
2015
Q3
$12.4M Sell
227,500
-32,500
-13% -$2.12M 0.21% 38
2015
Q2
$17.5M Hold
260,000
0.25% 37
2015
Q1
$15.2M Buy
+260,000
New +$15.7M 0.22% 37
2014
Q4
Sell
-52,569
Closed -$3.04M 129
2014
Q3
$3.04M Buy
+52,569
New +$2.92M 0.04% 66

Other funds holding ABBV

C WorldWide Group's ABBV Position: Q2 2019 in Review

C WorldWide Group sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 125,780 shares — an estimated $10.1M sold.

C WorldWide Group first reported a position in ABBV in Q3 2014 and held it in 18 quarters. The position peaked at $17.5M in Q2 2015. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • C WorldWide Group reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 125,780 AbbVie shares in Q2 2019, an estimated $10.1M.
  • C WorldWide Group first reported a position in AbbVie in Q3 2014 and held it in 18 quarters.
  • C WorldWide Group's AbbVie position peaked at $17.5M in Q2 2015.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.